Gail Sofer, BioPharm EAB Member, Retires from GE
Gail Sofer, a member of BioPharm International’s Editorial Advisory Board, has retired from her position as director of regulatory compliance at GE Healthcare.
Gail Sofer, a member of BioPharm International’s Editorial Advisory Board, has retired from her position as director of regulatory compliance at GE Healthcare. Sofer is a well-known figure in the biotechnology/biologics industry, where she worked for more than 26 years, most recently focusing on process development and validation and the designing in of regulatory compliance. In addition, she has taught courses on biotechnology for more than ten years and published extensively on downstream processing, virus inactivation, and validation, including co-editing and authoring several books. She continues to serve on the PDA Board of Directors, the PDA Biotech Advisory Board, and the EAB of BioPharm International. Following her retirement from GE Healthcare, Sofer plans to offer consulting services on biotechnology process validation.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
